Livforsakringsbolaget Skandia Omsesidigt grew its holdings in shares of Cencora, Inc. (NYSE:COR – Free Report) by 9.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,075 shares of the company’s stock after purchasing an additional 5,500 shares during the period. Cencora comprises about 0.8% of Livforsakringsbolaget Skandia Omsesidigt’s portfolio, making the stock its 28th biggest position. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Cencora were worth $19,497,000 at the end of the most recent quarter.
Other hedge funds have also made changes to their positions in the company. Nordea Investment Management AB raised its stake in shares of Cencora by 3.8% in the fourth quarter. Nordea Investment Management AB now owns 1,256,356 shares of the company’s stock valued at $426,715,000 after acquiring an additional 45,712 shares in the last quarter. Groupama Asset Managment purchased a new position in Cencora in the third quarter valued at $1,225,000. Assetmark Inc. grew its stake in Cencora by 57.0% during the 4th quarter. Assetmark Inc. now owns 67,281 shares of the company’s stock worth $22,724,000 after purchasing an additional 24,431 shares in the last quarter. ExodusPoint Capital Management LP acquired a new position in Cencora during the 4th quarter worth $16,487,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Cencora by 162.4% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 289,370 shares of the company’s stock worth $97,735,000 after purchasing an additional 179,086 shares during the period. Institutional investors and hedge funds own 97.52% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have issued reports on the company. Barclays reduced their price target on Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 10th. UBS Group raised their target price on shares of Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a report on Thursday, May 7th. William Blair assumed coverage on shares of Cencora in a research note on Tuesday, April 28th. They issued a “market perform” rating for the company. Robert W. Baird lowered their price target on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a report on Thursday, May 7th. Finally, Wells Fargo & Company dropped their price objective on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research report on Monday, May 11th. Eleven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $367.75.
Cencora Stock Down 1.3%
COR stock opened at $302.16 on Wednesday. The stock has a market cap of $58.79 billion, a P/E ratio of 23.17, a PEG ratio of 1.70 and a beta of 0.58. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. Cencora, Inc. has a twelve month low of $244.82 and a twelve month high of $377.54. The company’s 50 day moving average is $277.12 and its two-hundred day moving average is $318.31.
Cencora (NYSE:COR – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). The company had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company’s quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Research analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.
Cencora Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were paid a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.8%. The ex-dividend date was Friday, May 15th. Cencora’s dividend payout ratio is currently 18.40%.
Cencora announced that its Board of Directors has initiated a share repurchase plan on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to repurchase up to 3.9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.
Insider Transactions at Cencora
In other news, Director Lauren M. Tyler acquired 550 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were bought at an average price of $270.23 per share, with a total value of $148,626.50. Following the completion of the acquisition, the director owned 4,359 shares in the company, valued at $1,177,932.57. This trade represents a 14.44% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.38% of the stock is owned by corporate insiders.
About Cencora
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.
Featured Stories
- Five stocks we like better than Cencora
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
